Try the Demo today!
| SEC Filing | Insider | Company | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Return |
|---|---|---|---|---|---|---|---|---|---|
| 08-Jun-23 7:00 AM View:  | Shallcross Steven A CEO and CFO Director | Pipex Pharmaceuticals, Inc. (TOVX) | 07-Jun-23 | Purchase | 14,000 | $0.69 | $9,703.40 | 6% 236.0K to 250.0K | |
| 07-Jun-23 7:00 AM View: | Shallcross Steven A CEO and CFO Director | Pipex Pharmaceuticals, Inc. (TOVX) | 06-Jun-23 | Purchase | 26,000 | $0.63 | $16,452.80 | 12% 210.0K to 236.0K | |
| 13-Feb-23 6:06 AM View: | Shallcross Steven A CEO and CFO Director | Pipex Pharmaceuticals, Inc. (TOVX) | 10-Feb-23 | Purchase | 25,000 | $1.04 | $26,075.00 | 14% 185.0K to 210.0K | |
| 03-Feb-23 6:02 AM View: | Shallcross Steven A CEO and CFO Director | Pipex Pharmaceuticals, Inc. (TOVX) | 02-Feb-23 | Purchase | 25,000 | $0.94 | $23,512.50 | 16% 160.0K to 185.0K | |
| 26-Jan-23 6:03 AM View: | Shallcross Steven A CEO and CFO Director | Pipex Pharmaceuticals, Inc. (TOVX) | 25-Jan-23 | Purchase | 25,000 | $0.87 | $21,825.00 | 19% 135.0K to 160.0K | |
| 23-Jan-23 6:08 AM View: | Shallcross Steven A CEO and CFO Director | Pipex Pharmaceuticals, Inc. (TOVX) | 20-Jan-23 | Purchase | 25,000 | $0.75 | $18,705.00 | 23% 110.0K to 135.0K | |
| 03-Jan-23 6:04 AM View: | Shallcross Steven A CEO and CFO Director | Pipex Pharmaceuticals, Inc. (TOVX) | 29-Dec-22 | Purchase | 100,000 | $0.44 | $43,700.00 | 1000% 10.0K to 110.0K | |
| 10-May-21 5:30 PM View: | Shallcross Steven A CEO and CFO Director | Pipex Pharmaceuticals, Inc. (TOVX) | 10-May-21 | Market Purchase | 50,000 | $0.49 | $24,595.00 | 100% 50.0K to 100.0K | 6% |
| 26-Aug-19 5:00 PM View: | Shallcross Steven A CEO and CFO Director | Pipex Pharmaceuticals, Inc. (TOVX) | 23-Aug-19 | Market Purchase | 50,000 | $0.42 | $20,785.00 | 100% 0 to 50.0K | 101% |
| 03-Apr-19 5:13 PM View: | Kirk Randal J 10% Owner | Pipex Pharmaceuticals, Inc. (TOVX) | 03-Apr-19 | Market Sale | 95,241 | $0.65 | $61,906.60 | (29%) 322.92K to 227.67K | (15%) |
| 03-Apr-19 5:13 PM View: | Kirk Randal J 10% Owner | Pipex Pharmaceuticals, Inc. (TOVX) | 02-Apr-19 | Market Sale | 13,646 | $0.66 | $9,006.36 | (4%) 336.56K to 322.92K | (15%) |
| 03-Apr-19 5:13 PM View: | Kirk Randal J 10% Owner | Pipex Pharmaceuticals, Inc. (TOVX) | 01-Apr-19 | Market Sale | 41,678 | $0.67 | $27,924.30 | (11%) 378.24K to 336.56K | (13%) |
| 16-Mar-17 6:52 PM View: | Kraws Jeffrey J Director | Pipex Pharmaceuticals, Inc. (TOVX) | 14-Mar-17 | Option Exercise | 228,773 | $0.09 | $20,589.60 | 100% 0 to 228.77K | |
| 18-Nov-16 11:12 AM View: | Tarriff Scott Director | Pipex Pharmaceuticals, Inc. (TOVX) | 18-Nov-16 | Grant | 300,000 | -- | -- | 100% 0 to 300.0K | |
| 04-Sep-15 2:24 PM View: | Kirk Randal J 10% Owner | Pipex Pharmaceuticals, Inc. (TOVX) | 02-Sep-15 | Purchase | 937,500 | $3.20 | $3,000,000.00 | 8% 12.3M to 13.24M | |
| 02-Apr-15 3:06 PM View: | Wolf Jeffrey Alan Director | Pipex Pharmaceuticals, Inc. (TOVX) | 01-Apr-15 | Option Exercise | 10,842 | $0.09 | $975.78 | 100% 0 to 10.84K | |
| 27-May-14 6:10 AM View: | Ballantyne Charles Evan CHIEF FINANCIAL OFFICER | Pipex Pharmaceuticals, Inc. (TOVX) | 22-May-14 | Market Purchase | 10,000 | $1.35 | $13,500.00 | 100% 0 to 10.0K | (99%) |
| 02-May-14 4:30 PM View: | Kanzer Steve H 10% Owner | Pipex Pharmaceuticals, Inc. (TOVX) | 30-Apr-14 | Market Sale | 5,003,020 | $1.43 | $7,154,330.00 | (70%) 7.2M to 2.2M | 99% |
| 30-Apr-14 5:01 PM View: | Kanzer Steve H 10% Owner | Pipex Pharmaceuticals, Inc. (TOVX) | 29-Apr-14 | Market Sale | 87,935 | $2.98 | $262,046.00 | (1%) 7.29M to 7.2M | 99% |
| 30-Apr-14 5:01 PM View: | Kanzer Steve H 10% Owner | Pipex Pharmaceuticals, Inc. (TOVX) | 28-Apr-14 | Market Sale | 175,177 | $2.86 | $501,006.00 | (2%) 7.46M to 7.29M | 99% |
| 19-Dec-13 4:56 PM View: | Kirk Randal J 10% Owner | Pipex Pharmaceuticals, Inc. (TOVX) | 17-Dec-13 | Market Purchase | 2,500,000 | $1.00 | $2,500,000.00 | 26% 9.8M to 12.3M | (98%) |
| 07-Jan-13 4:08 PM View: | Riley Jeffrey Scott CEO and President Director | Pipex Pharmaceuticals, Inc. (TOVX) | 07-Jan-13 | Private Purchase | 2,900 | $0.17 | $506.49 | 39% 7.5K to 10.4K | |
| 04-Jan-13 4:30 PM View: | Riley Jeffrey Scott CEO and President Director | Pipex Pharmaceuticals, Inc. (TOVX) | 03-Jan-13 | Market Purchase | 2,000 | $1.71 | $3,420.00 | 36% 5.5K to 7.5K | (99%) |
| 03-Jan-13 4:47 PM View: | Riley Jeffrey Scott CEO and President Director | Pipex Pharmaceuticals, Inc. (TOVX) | 03-Jan-13 | Market Purchase | 2,800 | $1.75 | $4,899.72 | 104% 2.7K to 5.5K | (99%) |
| 03-Jan-13 4:47 PM View: | Riley Jeffrey Scott CEO and President Director | Pipex Pharmaceuticals, Inc. (TOVX) | 02-Jan-13 | Market Purchase | 2,700 | $1.78 | $4,805.73 | 100% 0 to 2.7K | (99%) |
| 31-Oct-12 3:50 PM View: | Kirk Randal J 10% Owner | Pipex Pharmaceuticals, Inc. (TOVX) | 29-Oct-12 | Private Purchase | 3,125,000 | $1.60 | $5,000,000.00 | 47% 6.68M to 9.8M | |
| 31-Aug-11 5:27 PM View: | Kuo James S Chairman, CEO & President Director | Pipex Pharmaceuticals, Inc. (TOVX) | 30-Aug-11 | Market Purchase | 4,500 | $0.69 | $3,102.75 | 100% 0 to 4.5K | (97%) |
| 10-Dec-09 5:12 PM View: | Lyon Lyman Max Jr CEO & President Director | Pipex Pharmaceuticals, Inc. (TOVX) | 09-Dec-09 | Disposition | 25,000 | $0.45 | $11,255.00 | (100%) 25.0K to 0 | 96% |
| 10-Dec-09 5:12 PM View: | Lyon Lyman Max Jr CEO & President Director | Pipex Pharmaceuticals, Inc. (TOVX) | 08-Dec-09 | Disposition | 20,000 | $0.48 | $9,526.00 | (44%) 45.0K to 25.0K | 96% |
| 08-Dec-09 5:27 PM View: | Lyon Lyman Max Jr CEO & President Director | Pipex Pharmaceuticals, Inc. (TOVX) | 07-Dec-09 | Grant | 45,000 | $0.38 | $17,100.00 | 100% 0 to 45.0K | |
| 15-Apr-08 11:11 AM View: | Kanzer Steve H CEO Director 10% Owner | Pipex Pharmaceuticals, Inc. (TOVX) | 11-Apr-08 | Market Purchase | 50,000 | $0.89 | $44,427.80 | < 1% 7.41M to 7.46M | (98%) |
| 04-Feb-08 3:50 PM View: | Rudick A Joseph Director | Pipex Pharmaceuticals, Inc. (TOVX) | 29-Jan-08 | Option Exercise | 27,106 | $0.09 | $2,439.54 | 90% 30.16K to 57.27K | |
| 13-Nov-07 12:56 PM View: | Dorman Daniel J Director | Pipex Pharmaceuticals, Inc. (TOVX) | 09-Nov-07 | Private Purchase | 253,731 | $2.22 | $563,283.00 | 50% 507.46K to 761.19K | |
| 13-Nov-07 9:49 AM View: | Ridgeback Capital Investmen... 10% Owner | Pipex Pharmaceuticals, Inc. (TOVX) | 09-Nov-07 | Exercise (in-the money or at-the-money) | 618,855 | $0.74 | $457,953.00 | 50% 1.24M to 1.86M | |
| 26-Jul-07 5:07 PM View: | Kanzer Steve H CEO Director 10% Owner | Pipex Pharmaceuticals, Inc. (TOVX) | 25-Jul-07 | Market Purchase | 14,300 | $7.22 | $103,281.00 | < 1% 7.4M to 7.41M | (100%) |
| 25-Jul-07 3:41 PM View: | Kanzer Steve H CEO Director 10% Owner | Pipex Pharmaceuticals, Inc. (TOVX) | 24-Jul-07 | Market Purchase | 8,000 | $7.13 | $57,025.00 | < 1% 7.39M to 7.4M | (100%) |
| 24-Jul-07 3:41 PM View: | Kanzer Steve H CEO Director 10% Owner | Pipex Pharmaceuticals, Inc. (TOVX) | 23-Jul-07 | Market Purchase | 29,700 | $6.75 | $200,351.00 | < 1% 7.36M to 7.39M | (100%) |
| 19-Jul-07 5:06 PM View: | Kanzer Steve H CEO Director 10% Owner | Pipex Pharmaceuticals, Inc. (TOVX) | 17-Jul-07 | Market Purchase | 25,000 | $5.25 | $131,171.00 | < 1% 7.33M to 7.36M | (100%) |
| 17-Jul-07 1:21 PM View: | Bisgaier Charles Phd President Director | Pipex Pharmaceuticals, Inc. (TOVX) | 16-Jul-07 | Market Purchase | 10,000 | $4.64 | $46,400.00 | 3% 322.09K to 332.09K | (100%) |
| 18-Jul-07 10:33 AM View: | Kanzer Steve H CEO Director 10% Owner | Pipex Pharmaceuticals, Inc. (TOVX) | 16-Jul-07 | Market Purchase | 81,000 | $4.84 | $391,962.00 | 1% 7.25M to 7.33M | (100%) |
| 15-May-07 8:30 AM View: | Kanzer Steve H Chief Executive Officer Director 10% Owner | Pipex Pharmaceuticals, Inc. (TOVX) | 11-May-07 | Market Purchase | 26,500 | $5.30 | $140,350.00 | < 1% 21.68M to 21.71M | (100%) |
| 18-Apr-07 12:17 PM View: | Kanzer Steve H Chief Executive Officer Director 10% Owner | Pipex Pharmaceuticals, Inc. (TOVX) | 17-Apr-07 | Market Purchase | 66,000 | $2.02 | $133,640.00 | < 1% 21.62M to 21.68M | (100%) |
| 18-Apr-07 12:17 PM View: | Kanzer Steve H Chief Executive Officer Director 10% Owner | Pipex Pharmaceuticals, Inc. (TOVX) | 16-Apr-07 | Market Purchase | 161,000 | $1.94 | $311,940.00 | < 1% 21.45M to 21.62M | (100%) |
| 28-Feb-07 1:37 PM View: | Kanzer Steve H Chief Executive Officer Director 10% Owner | Pipex Pharmaceuticals, Inc. (TOVX) | 27-Feb-07 | Grant | 100,000 | $1.25 | $125,000.00 | < 1% 21.35M to 21.45M | (99%) |
| 22-Feb-07 12:56 PM View: | Kanzer Steve H Chief Executive Officer Director 10% Owner | Pipex Pharmaceuticals, Inc. (TOVX) | 21-Feb-07 | Grant | 95,238 | $1.05 | $99,999.90 | < 1% 21.26M to 21.35M | (99%) |
| 18-Jul-07 10:33 AM View: | Kanzer Steve H Chief Executive Officer Director | Pipex Pharmaceuticals, Inc. (TOVX) | 02-Nov-06 | Purchase | 7,086,380 | $0.67 | $4,747,870.00 | 4237% 167.24K to 7.25M | |
| 17-Jul-07 1:21 PM View: | Bisgaier Charles Phd Director | Pipex Pharmaceuticals, Inc. (TOVX) | 02-Nov-06 | Grant | 99,104 | $2.02 | $200,190.00 | 44% 222.98K to 322.09K | |
| 19-Jul-07 5:06 PM View: | Kanzer Steve H Chief Executive Officer Director | Pipex Pharmaceuticals, Inc. (TOVX) | 31-Oct-06 | Purchase | 7,086,380 | -- | -- | 2855% 248.24K to 7.33M | |
| 26-Jul-07 5:07 PM View: | Kanzer Steve H Chief Executive Officer Director | Pipex Pharmaceuticals, Inc. (TOVX) | 31-Oct-06 | Purchase | 7,086,380 | -- | -- | 2279% 310.94K to 7.4M | |
| 24-Jul-07 3:41 PM View: | Kanzer Steve H Chief Executive Officer Director | Pipex Pharmaceuticals, Inc. (TOVX) | 31-Oct-06 | Purchase | 7,086,380 | -- | -- | 2593% 273.24K to 7.36M |
